SAN FRANCISCO & NEW YORK – Clarify Health Solutions has closed $57 million in a Series B financing round to fuel the company’s growth in the personalization and optimization of health care. Clarify’s solutions use predictive analytics and machine learning on a comprehensive data set of more than 20 terabytes—representing clinical, claims, social determinant, laboratory and prescription data—to provide actionable insights and automate care navigation. The company’s Care Journey Platform enables doctors to match patients to the most appropriate care, while patients receive real-time visibility and guidance. “We are entering a new era, where technology can help us to reimagine care delivery,” said Dr. Jean Drouin, CEO and co-founder of Clarify Health Solutions, in a statement. “We have accepted for far too long that an accessible, service-oriented and customer-centric experience is simply unattainable in health care.” Clarify plans to use the new funding to expand its clinical transformation, sales, engineering and data science teams, to acquire new data assets, and to accelerate the development of its digital care guidance platform, said Drouin.
You are here: / / Clarify Health plans to grow with $57M in new funding